Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition

British Journal of Cancer

Volumn 105, Issue 9, 2011, Pages 1436-1442

  Tsilidis, K K ^a   Allen, N E ^a   Key, T J ^a   Dossus, L ^b   Lukanova, A ^b   Bakken, K ^c   Lund, E ^c   Fournier, A ^d,e   Overvad, K ^f   Hansen, L ^g   Tjonneland A ^g   Fedirko, V ^h   Rinaldi, S ^h   Romieu, I ^h   Clavel Chapelon, F ^d,e   Engel, P ^d,e   Kaaks, R ^b   Schutze M ⁱ   Steffen, A ⁱ   Bamia, C ^j   Trichopoulou, A ^j,k   Zylis, D ^j   Masala, G ^l   Pala, V ^m   Galasso, R ⁿ   Tumino, R ^o   Sacerdote, C ^p   Bueno De Mesquita, H B ^q,r   Van Duijnhoven, F J B ^q   Braem, M G M ^r   Onland Moret, N C ^r   Gram, I T ^c   Rodriguez L ^s   Travier, N ^t   Sanchez M J ^u,v   Huerta, J M ^v,w   Ardanaz, E ^v,x   Larraaga N ^v,y   Jirstrom K ^z   Manjer, J ^z   Idahl, A ^aa   Ohlson, N ^aa   Khaw, K T ^ab   Wareham, N ^ab   Mouw, T ^ac   Norat, T ^ac   Riboli, E ^ac   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF TROMSØ   (Norway)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f AARHUS UNIVERSITY   (Denmark)

^g INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^h INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

ⁱ GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^j UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^k HELLENIC HEALTH FOUNDATION   (Greece)

^l CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^o CIVILE M P AREZZO HOSPITAL   (Italy)

^p Human Genetics Foundation   (Italy)

^q NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^r UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^s Health and Health Care Services Council   (Spain)

^t CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^u ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^v CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^w Murcia Regional Health Authority   (Spain)

^x INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^y Basque Government   (Spain)

^z LUND UNIVERSITY HOSPITAL   (Sweden)

^aa UMEÅ UNIVERSITY   (Sweden)

^ab UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ac IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

cohort study; oral contraceptive use; ovarian cancer; reproductive history

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY MASS; CANCER RISK; EUROPE; FEMALE; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; NULLIPARA; OVARIECTOMY; OVARY CANCER; PARITY; PRIORITY JOURNAL; REPRODUCTION; RISK ASSESSMENT; SENESCENCE; SMOKING;

ADULT; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; OVARIAN NEOPLASMS; PARITY; PREGNANCY; REPRODUCTIVE HISTORY; RISK;

EID: 80055013415     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.371     Document Type: Article

References (41)

1. Adami HO, Hsieh CC, Lambe M, Trichopoulos D, Leon D, Persson I, Ekbom A, Janson PO (1994) Parity, age at first childbirth, and risk of ovarian cancer. Lancet 344: 1250-1254 (Pubitemid 24334680)
2. Albrektsen G, Heuch I, Kvale G (1996) Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study. Cancer Causes Control 7: 421-427 (Pubitemid 26228331)
3. American Cancer Society (2007) Global Cancer Facts and Figures 2007. American Cancer Society: Atlanta
4. Beral V, Doll R, Hermon C, Peto R, Reeves G (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemio-logical studies including 23257 women with ovarian cancer and 87 303 controls. Lancet 371: 303-314
5. Booth M, Beral V, Smith P (1989) Risk factors for ovarian cancer: a case-control study. Br J Cancer 60: 592-598 (Pubitemid 19251457)
6. Braem MG, Onland-Moret NC, van den Brandt PA, Goldbohm RA, Peeters PH, Kruitwagen RF, Schouten LJ (2010) Reproductive and hormonal factors in association with ovarian cancer in the Netherlands Cohort Study. Am J Epidemiol 172: 1181-1189
7. Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71: 717-721 (Pubitemid 14232385)
8. Cramer DW, Xu H (1995) Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer. Ann Epidemiol 5: 310-314
9. Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE (2007) Breastfeeding and risk of ovarian cancer in two prospective cohorts. Cancer Causes Control 18: 517-523 (Pubitemid 46684826)
10. Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, Olsen A, Overvad K, Clavel-Chapelon F, Fournier A, Chabbert-Buffet N, Boeing H, Schütze M, Trichopoulou A, Trichopoulos D, Lagiou P, Palli D, Krogh V, Tumino R, Vineis P, Mattiello A, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Dumeaux V, Redondo ML, Duell E, Sanchez-Cantalejo E, Arriola L, Chirlaque MD, Ardanaz E, Manjer J, Borgquist S, Lukanova A, Lundin E, Khaw KT, Wareham N, Key T, Chajes V, Rinaldi S, Slimani N, Mouw T, Gallo V, Riboli E (2010) Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 127: 442-451
11. Fathalla MF (1971) Incessant ovulation-a factor in ovarian neoplasia? Lancet 2: 163
12. Gwinn ML, Lee NC, Rhodes PH, Layde PM, Rubin GL (1990) Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 43: 559-568 (Pubitemid 20178545)
13. Hankinson SE, Colditz GA, Hunter DJ, Willett WC, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE (1995) A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer 76: 284-290
14. Harlow BL, Cramer DW, Bell DA, Welch WR (1992) Perineal exposure to talc and ovarian cancer risk. Obstet Gynecol 80: 19-26
15. Jordan SJ, Siskind V, Green AC, Whiteman DC, Webb PM (2010) Breastfeeding and risk of epithelial ovarian cancer. Cancer Causes Control 21: 109-116
16. Jordan SJ, Webb PM, Green AC (2005) Height, age at menarche, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 14: 2045-2048 (Pubitemid 41161222)
17. Kvale G, Heuch I, Nilssen S, Beral V (1988) Reproductive factors and risk of ovarian cancer: a prospective study. Int J Cancer 42: 246-251
18. Lau KM, Mok SC, Ho SM (1999) Expression of human estrogen receptor-alpha and-beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 96: 5722-5727 (Pubitemid 29234685)
19. Mogren I, Stenlund H, Hogberg U (2001) Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer. Acta Oncol 40: 849-854 (Pubitemid 34082732)
20. Moorman PG, Palmieri RT, Akushevich L, Berchuck A, Schildkraut JM (2009) Ovarian cancer risk factors in African-American and white women. Am J Epidemiol 170: 598-606
21. Mukherjee K, Syed V, Ho SM (2005) Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells. Oncogene 24: 4388-4400 (Pubitemid 40961762)
22. Negri E, Franceschi S, Tzonou A, Booth M, La Vecchia C, Parazzini F, Beral V, Boyle P, Trichopoulos D (1991) Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer. Int J Cancer 49: 50-56
23. Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH (2004) Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. Fertil Steril 82: 186-195 (Pubitemid 38968797)
24. Piper JM, Kennedy DL (1987) Oral contraceptives in the United States: trends in content and potency. Int J Epidemiol 16: 215-221 (Pubitemid 17108837)
25. Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, Quinn M, Wright G, Russell P, Susil B (1995) Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer 62: 678-684
26. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjønneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, González CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5: 1113-1124 (Pubitemid 36313608)
27. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR (2002) Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Am J Epidemiol 156: 363-373 (Pubitemid 34858005)
28. Riman T, Nilsson S, Persson IR (2004) Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 83: 783-795 (Pubitemid 39179432)
29. Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90: 1774-1786 (Pubitemid 28559889)
30. Risch HA, Marrett LD, Howe GR (1994) Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 140: 585-597 (Pubitemid 24313016)
31. Schildkraut JM, Cooper GS, Halabi S, Calingaert B, Hartge P, Whittemore AS (2001) Age at natural menopause and the risk of epithelial ovarian cancer. Obstet Gynecol 98: 85-90 (Pubitemid 32622769)
32. Schoenfeld D (1982) Partial residuals for the proportional hazards regression model. Biometrika 69: 239-241
33. Stadel BV (1975) Letter: The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 123: 772-774
34. Syed V, Ulinski G, Mok SC, Yiu GK, Ho SM (2001) Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res 61: 6768-6776 (Pubitemid 32896499)
35. Thorogood M, Villard-Mackintosh L (1993) Combined oral contraceptives: risks and benefits. Br Med Bull 49: 124-139 (Pubitemid 23034235)
36. Titus-Ernstoff L, Perez K, Cramer DW, Harlow BL, Baron JA, Greenberg ER (2001) Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer 84: 714-721 (Pubitemid 32239010)
37. Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Kolonel LN, Nomura AM, Terada KY, Carney ME, Sobin LH (2003) Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 158: 629-638 (Pubitemid 37175510)
38. Vachon CM, Mink PJ, Janney CA, Sellers TA, Cerhan JR, Hartmann L, Folsom AR (2002) Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women. Epidemiology 13: 66-71 (Pubitemid 34031512)
39. Whiteman DC, Siskind V, Purdie DM, Green AC (2003) Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 12: 42-46 (Pubitemid 36110156)
40. Whittemore AS, Harris R, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136: 1184-1203 (Pubitemid 23026890)
41. Zhang M, Lee AH, Binns CW (2004) Reproductive and dietary risk factors for epithelial ovarian cancer in China. Gynecol Oncol 92: 320-326 (Pubitemid 38147409)